Interrelationships of DNA-ploidy and cell proliferation markers with T- stage and N-stage in primary laryngeal tumors

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 2, 1998, Pages 303-308

  Struikmans, H ^a   Rutgers, D H ^a   Hordijk, G J ^a   Slootweg, P J ^a   Van Der Tweel, I ^b   Battermann, J J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cell proliferation markers; DNA ploidy; Flow cytometry; Laryngeal tumors; N stage; T stage

Indexed keywords

BROXURIDINE; DNA;

ADULT; ANEUPLOIDY; ARTICLE; CANCER STAGING; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DIPLOIDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LABELING INDEX; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

CELL DIVISION; DNA, NEOPLASM; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; S PHASE;

EID: 0032518465     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00575-0     Document Type: Article

References (34)

1. 1. Beck, H. P. Evaluation of flow cytometric data of human tumours. Correction procedures for background and cell aggregations. Cell Tissue Kinet. 13:173-181; 1980.
2. 2. Begg, A. C.; McNally N. J.; Shrieve, D. C. A method to measure the duration of the DNA synthesis and the potential volume doubling time from a single sample. Cytometry 6:620-626; 1985.
3. 3. Begg, A. C.; Hofland, I.; Moonen, L.; Bartelink, H.; Schraub, S.; Bontemps, P.; Lefur, R.; Bogaert, W. van den; Glabbeke, M. van; Horiot, J. C. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumours: An interim report. Int. J. Radiat. Oncol. Biol, Phys. 19:1449-1453; 1990.
4. 4. Begg, A. C.; Hofland, I.; Glabbeke, M. van; Bartelink, H.; Horiot, J. C. Predictive value of potential doubling time for radiotherapy of head and neck tumour patients: Results from the EORTC cooperative trial 22851. Semin. Radiat. Oncol. 1:22-25; 1992.
5. 5. Benazzo, M.; Mevio, E.; Occhini, A.; Francini, G.; Danova, M. Proliferative characteristics of head and neck tumours. ORL 57:39-43; 1995.
6. 6. Bennett, M. H.; Wilson, G. D.; Dishe, S.; Saunders, M. I.; Martindale, C. A.; Robinson, B. M.; O'Halloran, A. E.; Leslie, M. D.; Laing, J. H. E. Tumour proliferation assessed by combined histological and flow cytometric analysis: Implication for therapy in squamous cell carcinoma in the head and neck. Br. J. Cancer 65:870-878; 1992.
7. 7. Born, R.; Hug, O.; Trott, K. R. The effect of prolonged hypoxia on growth and viability of chinese hamster cells. Int. J. Radiat. Oncol. Biol. Phys. 1:687-697; 1993.
8. 8. Bourhis, J.; Rendale, R.; Hill, C.; Bosq, J.; Janot, F.; Altal, P.; Fortin, A.; Marandas, P.; Schwaab, G.; Wibault, P.; Malaise, E. P.; Bobin, S.; Luboinski, B.; Eschwege, F.; Wilson, G. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 Gy in 7 weeks. Int. J. Radiat. Oncol. Biol. Phys. 35:471-476; 1996.
9. 9. Cooke, D.; Cooke, T. G.; Forster, G.; Jones, A. S.; Stell, P. M. Prospective evaluation of cell kinetics in head and neck squamous carcinoma: The relationship to tumour factors and survival. Br. J. Cancer 69:717-720; 1994.
10. 10. Corvo, R.; Giaretti, W.; Sanguined, G.; Geido, E.; Orecchia, R.; Guenzi, M.; Margarino, G.; Bacigalupo, A.; Garaventa, G.; Barbieri, M.; Vitale, V. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. J. Clin. Oncol. 13:1843-1850; 1995.
11. 11. Fowler, J. F. Rapid repopulation in radiotherapy: Debate on mechanisms, the phantom of tumour treatment - Continually rapid repopulation unmasked. Radiother. Oncol. 22:156-158; 1991.
12. 12. Fu, K. K.; Hammond, E.; Pajak, T. F.; Clery, M.; Scotte Dogett, R. L.; Byhardt, R. W.; McDonald, S.; Cooper, J. S. Flow cytometric quantification of the proliferation associated nuclear antigen p105 and DNA content in advanced head & neck cancers: Results of RTOG 91-08. Int. J. Radiat. Oncol. Biol. Phys. 29:661-671; 1994.
13. 13. Guo, Y. C.; Santo de, L.; Osetinsky, G. V. Prognostic implications of nuclear DNA content in head and neck cancer. Otolaryngol. Head Neck Surg. 100:95-98; 1989.
14. 14. Kearsly, J. H.; Bryson, G.; Battistutta, D.; Collins, R. J. Prognostic importance of cellular DNA content in head- and-neck squamous-cell cancers. A comparison of retrospective and prospective series. Int. J. Cancer 47:31-37; 1991.
15. 15. Linden, P. M. van der. An iterative method of analysis for DNA histograms. Acta Pathol. Microbiol. Scand. Suppl. 274: 133-137; 1981.
16. 16. Ravasz, L. A.; Hordijk, G. J.; Slootweg, P. J.; Smit, F.; Tweel I. van der. Uni- and multivariate analysis of eight indications for postoperative radiotherapy and their significance for local-regional cure in head and neck cancer. J. Laryngol. Otol. 107:437-440; 1993.
17. 17. Rua, S.; Comino, A.; Fruttero, A.; Cera, G.; Semeria, C.; Lanzillotta, L.; Boffetta, P. Relationship between histologic features, DNA flow cytometry, and clinical behaviour of squamous cell carcinoma of the larynx. Cancer 67:141-149; 1991.
18. 18. Rudoltz, M. S.; Benammar, A.; Mohiuddin, M. Does pathological node status affect local control in patients with carcinoma of the head and neck treated with radical surgery and postoperative radiotherapy? Int. J. Radiat. Oncol. Biol. Phys. 31:503-508; 1994.
19. 19. Sakr, W.; Hussan, M.; Zarbo, R. J.; Ensley, J.; Crissman, J. D. DNA quantitation and histologic characteristics of squamous cell carcinoma of the upper aerodigestive tract. Arch. Pathol. Lab. Med. 113:1009-1014; 1989.
20. 20. Schultz, H. S.; Begg, A. C.; Hofland, I.; Kummermehr, J.; Sund, M. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry. Br. J. Cancer 68: 1097-1103; 1993.
21. 21. Schutte, B.; Reynderd, M. M. J.; Assche, C. L. van; Hupperets, P. S.; Bosman, F. T.; Blijham, G. H. An improved method for the immunocytochemical detection of bromodeoxyuridine labelled nuclei using flow cytometry. Cytometry 8:372-376; 1987.
22. 22. Shrieve, D. C.; Begg, A. C. Cell cycle kinetics of aerated, hypoxic and re-aerated cells in vitro using flow cytometric determination of BrdUrd incorporation. Cell Tissue Kinet. 18:641-651; 1985.
23. 23. Stenfert Kroese, M. C.; Rutgers, D. H.; Wils, I. S.; Unnik, J. A. M. van; Roholl, P. J. M. The relevance of DNA index and proliferation rate in the grading of benign and malignant soft tissue tumours. Cancer 65:1782-1788; 1990.
24. 24. Terhaard, C. H. J.; Rutgers, D. H.; Ravasz, L. A.; Hordijk, G. J. DNA flow cytometry in advanced laryngeal cancer. In: Smee, R.; Bridger, G. P., eds. Laryngeal cancer; Proceedings of the 2nd world congress on laryngeal cancer; Sydney, 20-24 February 1994. Amsterdam: Elsevier Science B. V.; 1994: 161-165.
25. 25. Terry, N. H. A.; Peters, L. J. Editorial. The predictive value of tumour-cell kinetic parameters in radiotherapy: Considerations regarding data production and analysis. J. Clin. Oncol. 13:1833-1836; 1995.
26. 26. Toffoli, G.; Francin, G.; Barzan, L.; Cernigoi, C.; Carbone, A.; Sulfaro, S.; Franseschi, S.; Boiocchi, M. Brief report: Prognostic Importance of cellular DNA content in T1-2 N0 laryngeal squamous cell carcinomas treated with radiotherapy. Laryngoscope 105:649-652; 1995.
27. 27. Trott, K. R. Cell repopulation and overall treatment time. Int. J. Radiat. Oncol. Biol. Phys. 19:1071-1075; 1990.
28. 28. Tytor, M.; Olofsson, J.; Ledin, T.; Brunk, U.; Klintenberg, C. Squamous cell carcinoma of the oral cavity. A review of 176 cases with application of malignancy grading and DNA measurements. Clin. Otolaryngol. 15:235-252; 1990.
29. 29. Walter, M. A.; Peters, G. E.; Peiper, S. C. Predicting radioresistance in early glottic squamous cell carcinoma of DNA content. Ann. Otol. Rhinol. Laryngol. 100:523-526; 1991.
30. 30. Welkoborsky, H. J.; Dienes, H. P.; Hinni, M.; Mann, W. J. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumour front grading and proliferation markers. Ann. Otol. Rhinol. Laryngol. 104:503-510; 1995.
31. 31. Westerbeek, H. A.; Mooi, W. J.; Hilgers, F. J.; Baris, G.; Begg, A. C.; Balm, A. J. Ploidy status and the response of T1 glottic carcinoma to radiotherapy. Clin. Otolaryngol. 18:98-101; 1993.
32. 32. Wilson, G. D. Assessment of human tumour proliferation using bromodeoxyuridine - Current status. Acta Oncol. 30: 903-910; 1991.
33. 33. Wilson, D. W.; Dische, S.; Saunders, M. I. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother. Oncol. 36:189-197; 1995.
34. 34. Withers, H. R.; Taylor, J. M.; Maciejeski, B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol. 27:131-146; 1988.